Matters


Second Xarelto bellwether trial underway

May 25, 2017 - The second bellwether trial involving bleeding risks with the blood thinner Xarelto is slated to begin Tuesday following the Memorial Day holiday. Read More


First Xarelto trial set for April; blood thinner linked to severe bleeding risk

February 24, 2017 - The first of four bellwether trials for the Xarelto multidistrict litigation (MDL) is set to begin on April 24, 2017 in the Eastern District of Louisiana. Read More


Xarelto’s risks outweigh the benefits: Beasley Allen principal David Byrne explains

July 16, 2015 - Xarelto is in a new class of blood thinners designed to be an alternative to warfarin for the treatment of blood clots; however, unlike warfarin, there is no antidote to reverse the blood... Read More


New lawsuit targets bleeding risks with Xarelto blood thinnner

March 25, 2015 - Twelve people treated with Xarelto blood thinner have filed a lawsuit in California federal court claiming that they were not sufficiently warned that the drug could cause them to bleed... Read More


Blood thinner Xarelto dangers discussed by Beasley Allen attorney David Byrne

February 24, 2015 - Today on the Beasley Allen Report, host Gibson Vance interviews fellow Beasley Allen attorney David Byrne on the dangers of the prescription drug Xarelto. Read More


Beasley Allen lawyer Andy Birchfield appointed to leadership role in Xarelto blood thinner multidistrict litigation

February 10, 2015 - Beasley Allen Mass Torts section head Andy Birchfield has been appointed as Co-Lead Counsel for the Plaintiffs Steering Committee (PSC) in multidistrict litigation (MDL) over blood-thinner... Read More


Xarelto blood thinner lawsuits consolidated in Louisiana federal court; drug linked to serious bleeding risk

December 15, 2014 - Nearly two dozen lawsuits filed against Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Corp. over the blood thinner Xarelto have been consolidated in Louisiana federal... Read More


back to top